Pharmaceutical News/Pharmacy Samsung Biologics, National OncoVenture, and Eutilex obtains IND Approval from FDA February 11, 2021February 11, 2021 Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin More